YAP1 and PRDM14 converge to promote cell survival and tumorigenesis

Kim, M; Ly, SH; Xie, YT; Duronio, GN; Ford-Roshon, D; Hwang, JH; Sulahian, R; Rennhack, JP; So, J; Gjoerup, O; Talamas, JA; Grandclaudon, M; Long, HW; Doench, JG; Sethi, NS; Giannakis, M; Hahn, WC

Hahn, WC (通讯作者)，Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02215 USA.;Hahn, WC (通讯作者)，Broad Inst MIT & Harvard, Cambridge, MA 02142 USA.;Hahn, WC (通讯作者)，Brigham & Womens Hosp, Dept Med, Boston, MA 02115 USA.;Hahn, WC (通讯作者)，Harvard Med Sch, Boston, MA 02115 USA.

DEVELOPMENTAL CELL, 2022; 57 (2): 212

Abstract

The transcriptional co-activator YAP1 oncogene is the downstream effector of the Hippo pathway, which regulates tissue homeostasis, organ size, regene......

Full Text Link


Links

期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索